-
公开(公告)号:US20120214824A1
公开(公告)日:2012-08-23
申请号:US13315057
申请日:2011-12-08
IPC分类号: A61K31/519 , A61K31/47 , A61K31/4709 , A61K31/4162 , A61P3/10 , C07D491/052 , C07D409/08 , A61P35/00 , A61P25/28 , A61P25/16 , A61K31/436 , C07D471/04
CPC分类号: C07D409/04 , A61K31/519 , C07D215/54 , C07D487/04 , C07D491/04
摘要: The present invention is directed to compounds of Formulae (I), (II), (III), (IV), (V), (VI), (VII), and (VIII), pharmaceutical compositions thereof and methods of use thereof in the treatment of conditions associated with a dysfunction in proteostasis.
摘要翻译: 本发明涉及式(I),(II),(III),(IV),(V),(VI),(VII)和(VIII))的药物组合物及其使用方法 在治疗与蛋白酶抑制功能障碍有关的病症。
-
公开(公告)号:US20130072473A1
公开(公告)日:2013-03-21
申请号:US13467949
申请日:2012-05-09
申请人: Bradley Tait , Noel A. Powell , Matthew Cullen
发明人: Bradley Tait , Noel A. Powell , Matthew Cullen
IPC分类号: A61K31/55 , C07D495/04 , C07D333/68 , C07D417/04 , C07D307/85 , A61K31/4743 , A61K31/4745
CPC分类号: C07D495/04 , A61K31/40 , C07D307/85 , C07D333/68 , C07D417/04
摘要: The present invention is directed to compounds of Formulae (I), (IIa-IIh), (IIIa-IIIe), (IVa-IVc), (Va-V1), (VIa-VII), (VII), (VIII) and (IX), pharmaceutical compositions thereof and methods of use thereof in the treatment of conditions associated with a dysfunction in proteostasis.
摘要翻译: 本发明涉及式(I),(IIa-IIh),(IIIa-IIIe),(IVa-IVc),(Va-V1),(VIa-VII),(VII) 和(IX),其药物组合物及其在治疗与蛋白质降解功能障碍相关的病症中的用途。
-
公开(公告)号:US09556166B2
公开(公告)日:2017-01-31
申请号:US13468757
申请日:2012-05-10
申请人: Megan Foley , Bradley Tait , Matthew Cullen
发明人: Megan Foley , Bradley Tait , Matthew Cullen
IPC分类号: C07D401/06 , C07D403/06 , C07D405/06 , C07D471/04 , C07D207/333 , C07D207/337 , C07D231/12 , C07D249/06 , C07D263/32 , C07D275/02 , C07D295/185 , C07D333/20
CPC分类号: C07D403/06 , C07D207/333 , C07D207/337 , C07D231/12 , C07D249/06 , C07D263/32 , C07D275/02 , C07D295/185 , C07D333/20 , C07D333/22 , C07D401/06 , C07D405/06 , C07D471/04
摘要: The present invention is directed to compounds having the Formulae (Ia-Ie), (II), (IIIa-IIId), (IVa-IVc), (Va-Vb), (VIa-VIe), (VII), (VIIIa-VIIIc), and (IX), pharmaceutically acceptable salts, prodrugs and solvates thereof, compositions of any of thereof and methods for the treatment of a condition associated with a dysfunction in proteostasis comprising an effective amount of these compounds.
摘要翻译: 本发明涉及具有式(Ia-Ie),(II),(IIIa-IIId),(IVa-IVc),(Va-Vb),(VIa-VIe),(VII) -VIIIc)和(IX),其药学上可接受的盐,前药和溶剂化物,其任何组合物以及用于治疗与蛋白酶抑制功能障碍相关的病症的方法,其包含有效量的这些化合物。
-
公开(公告)号:US20120316193A1
公开(公告)日:2012-12-13
申请号:US13468757
申请日:2012-05-10
申请人: Megan Foley , Bradley Tait , Matthew Cullen
发明人: Megan Foley , Bradley Tait , Matthew Cullen
IPC分类号: C07D207/333 , C07D401/06 , C07D403/06 , C07D471/04 , C07D405/06 , C07D231/12 , C07D413/06 , C07D417/06 , C07D409/06 , C07D207/34 , A61K31/402 , A61K31/454 , A61K31/4025 , A61K31/4178 , A61K31/4745 , A61K31/404 , A61K31/4155 , A61K31/415 , A61K31/4535 , A61K31/4192 , A61P25/28 , A61P25/16 , A61P25/00 , A61P3/10 , A61P35/00 , C07D207/337
CPC分类号: C07D403/06 , C07D207/333 , C07D207/337 , C07D231/12 , C07D249/06 , C07D263/32 , C07D275/02 , C07D295/185 , C07D333/20 , C07D333/22 , C07D401/06 , C07D405/06 , C07D471/04
摘要: The present invention is directed to compounds having the Formulae (Ia-Ie), (II), (IIIa-IIId), (IVa-IVc), (Va-Vb), (VIa-VIe), (VII), (VIIIa-VIIIc), and (IX), pharmaceutically acceptable salts, prodrugs and solvates thereof, compositions of any of thereof and methods for the treatment of a condition associated with a dysfunction in proteostasis comprising an effective amount of these compounds.
摘要翻译: 本发明涉及具有式(Ia-Ie),(II),(IIIa-IIId),(IVa-IVc),(Va-Vb),(VIa-VIe),(VII) -VIIIc)和(IX),其药学上可接受的盐,前药和溶剂化物,其任何组合物以及用于治疗与蛋白酶抑制功能障碍相关的病症的方法,其包含有效量的这些化合物。
-
公开(公告)号:USD610092S1
公开(公告)日:2010-02-16
申请号:US29344378
申请日:2009-09-29
申请人: Javier Jimenez , Matthew Cullen
设计人: Javier Jimenez , Matthew Cullen
-
公开(公告)号:USD621358S1
公开(公告)日:2010-08-10
申请号:US29344381
申请日:2009-09-29
申请人: Javier Jimenez , Matthew Cullen
设计人: Javier Jimenez , Matthew Cullen
-
公开(公告)号:US20180310046A1
公开(公告)日:2018-10-25
申请号:US15961365
申请日:2018-04-24
申请人: Matthew Cullen
发明人: Matthew Cullen
IPC分类号: H04N21/414 , H04W76/10 , H04N21/4223 , H04N21/81
CPC分类号: G06Q30/0241 , G02B27/0093 , G02B27/0172 , G02B27/0179 , G06F1/163 , H04M2250/52 , H04N21/41407 , H04N21/4223 , H04N21/812 , H04N21/8153 , H04W4/80 , H04W76/10 , H04W88/02
摘要: A content distribution system featuring a plurality of wearable display devices. Wherein the wearable display devices may display be updated in real time via data connection with content from advertisers or other organizations.
-
公开(公告)号:US20180308120A1
公开(公告)日:2018-10-25
申请号:US15961383
申请日:2018-04-24
CPC分类号: G06Q30/0241 , G02B27/0093 , G02B27/0172 , G02B27/0179 , G06F1/163 , H04M2250/52 , H04N21/41407 , H04N21/4223 , H04N21/812 , H04N21/8153 , H04W4/80 , H04W76/10 , H04W88/02
摘要: A content distribution system featuring a plurality of wearable display devices. Wherein the wearable display devices may display be updated in real time via data connection with content from advertisers or other organizations.
-
-
-
-
-
-
-